Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin
- PMID: 23935101
- PMCID: PMC3784700
- DOI: 10.1074/jbc.M112.445098
Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin
Abstract
The vasopressin type 2 receptor (V2R) is a critical G protein-coupled receptor (GPCR) for vertebrate physiology, including the balance of water and sodium ions. It is unclear how its two native hormones, vasopressin (VP) and oxytocin (OT), both stimulate the same cAMP/PKA pathway yet produce divergent antinatriuretic and antidiuretic effects that are either strong (VP) or weak (OT). Here, we present a new mechanism that differentiates the action of VP and OT on V2R signaling. We found that vasopressin, as opposed to OT, continued to generate cAMP and promote PKA activation for prolonged periods after ligand washout and receptor internalization in endosomes. Contrary to the classical model of arrestin-mediated GPCR desensitization, arrestins bind the VP-V2R complex yet extend rather than shorten the generation of cAMP. Signaling is instead turned off by the endosomal retromer complex. We propose that this mechanism explains how VP sustains water and Na(+) transport in renal collecting duct cells. Together with recent work on the parathyroid hormone receptor, these data support the existence of a novel "noncanonical" regulatory pathway for GPCR activation and response termination, via the sequential action of β-arrestin and the retromer complex.
Keywords: Arrestin; G Protein-coupled Receptors (GPCR); Kidney Metabolism; Membrane Trafficking; Signaling; V2R.
Figures
Similar articles
-
β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor.Elife. 2023 Oct 19;12:RP87754. doi: 10.7554/eLife.87754. Elife. 2023. PMID: 37855711 Free PMC article.
-
Retromer terminates the generation of cAMP by internalized PTH receptors.Nat Chem Biol. 2011 May;7(5):278-84. doi: 10.1038/nchembio.545. Epub 2011 Mar 27. Nat Chem Biol. 2011. PMID: 21445058 Free PMC article.
-
Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).PLoS One. 2013 Jun 6;8(6):e65885. doi: 10.1371/journal.pone.0065885. Print 2013. PLoS One. 2013. PMID: 23762448 Free PMC article.
-
Non-canonical signaling of the PTH receptor.Trends Pharmacol Sci. 2012 Aug;33(8):423-31. doi: 10.1016/j.tips.2012.05.004. Epub 2012 Jun 16. Trends Pharmacol Sci. 2012. PMID: 22709554 Free PMC article. Review.
-
Endosomal parathyroid hormone receptor signaling.Am J Physiol Cell Physiol. 2022 Sep 1;323(3):C783-C790. doi: 10.1152/ajpcell.00452.2021. Epub 2022 Aug 1. Am J Physiol Cell Physiol. 2022. PMID: 35912987 Free PMC article. Review.
Cited by
-
Functional diversification of cell signaling by GPCR localization.J Biol Chem. 2024 Jan 23;300(3):105668. doi: 10.1016/j.jbc.2024.105668. Online ahead of print. J Biol Chem. 2024. PMID: 38272232 Free PMC article. Review.
-
Selective activation of intracellular β1AR using a spatially restricted antagonist.bioRxiv [Preprint]. 2023 Nov 22:2023.11.22.568314. doi: 10.1101/2023.11.22.568314. bioRxiv. 2023. PMID: 38045405 Free PMC article. Preprint.
-
From membrane to nucleus: A three-wave hypothesis of cAMP signaling.J Biol Chem. 2024 Jan;300(1):105497. doi: 10.1016/j.jbc.2023.105497. Epub 2023 Nov 26. J Biol Chem. 2024. PMID: 38016514 Free PMC article. Review.
-
β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor.Elife. 2023 Oct 19;12:RP87754. doi: 10.7554/eLife.87754. Elife. 2023. PMID: 37855711 Free PMC article.
-
β-Arrestin-independent endosomal cAMP signaling by a polypeptide hormone GPCR.Nat Chem Biol. 2024 Mar;20(3):323-332. doi: 10.1038/s41589-023-01412-4. Epub 2023 Sep 25. Nat Chem Biol. 2024. PMID: 37749347 Free PMC article.
References
-
- Lohse M. J., Benovic J. L., Codina J., Caron M. G., Lefkowitz R. J. (1990) β-Arrestin: a protein that regulates β-adrenergic receptor function. Science 248, 1547–1550 - PubMed
-
- Laporte S. A., Miller W. E., Kim K. M., Caron M. G. (2002) β-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a β-arrestin binding site in β2-adaptin. J. Biol. Chem. 277, 9247–9254 - PubMed
-
- Nelson C. D., Perry S. J., Regier D. S., Prescott S. M., Topham M. K., Lefkowitz R. J. (2007) Targeting of diacylglycerol degradation to M1 muscarinic receptors by β-arrestins. Science 315, 663–666 - PubMed
-
- Perry S. J., Baillie G. S., Kohout T. A., McPhee I., Magiera M. M., Ang K. L., Miller W. E., McLean A. J., Conti M., Houslay M. D., Lefkowitz R. J. (2002) Targeting of cyclic AMP degradation to β2-adrenergic receptors by β-arrestins. Science 298, 834–836 - PubMed
-
- Luttrell L. M., Lefkowitz R. J. (2002) The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455–465 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
